<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-19-45-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-19-6-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Headache Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of Antiepileptic Drugs in Migraine Prevention</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>2005</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>03</month>
<year>2016</year>
</pub-date>
<volume>19</volume>
<issue>6</issue>
<fpage>45</fpage>
<lpage>45</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2005 The Author(s)</copyright-statement>
<copyright-year>2005</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1111/j.1526-4610.2005.4501008.x" vol="45" page="S25">
<article-title>Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Abnormal brain excitability as a migraine trigger mechanism, and the use of antiepileptic drugs (AED) in migraine prevention, are reviewed from The Chicago Medical School, North Chicago, IL.</p>
</abstract>
<kwd-group>
<kwd>Antiepileptic Drugs</kwd>
<kwd>Magnetoencephalography</kwd>
<kwd>Preventing Migraine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Abnormal brain excitability as a migraine trigger mechanism, and the use of antiepileptic drugs (AED) in migraine prevention, are reviewed from The Chicago Medical School, North Chicago, IL. Brain imaging with functional MRI and magnetoencephalography (MEG) have shown that the migraine aura is linked with an abnormal electric and metabolic event consistent with the cortical spreading depression of Leao. Visual activation monitored by MEG and fMRI confirm hyperexcitability of the occipital cortex with triggering of the migraine aura. Low systemic or brain magnesium levels may be involved in the abnormal brain excitability associated with migraine. The comorbidity of migraine and epilepsy may be explained by a common state of brain hyperexcitability. Several antiepileptic drugs have a moderate degree of efficacy in preventing migraine attacks. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. The value of the EEG in children with migraine is controversial, and the EEG is not generally recommended as a routine evaluation (<bold>Progress in Pediatric Neurology III,</bold> PNB Publishers, 1997;ppl65-194) [<xref ref-type="bibr" rid="CIT0002">2</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>]. Kramer et al found epileptic EEGs in 11% of children with both migraine and tension type headaches; the incidence was 26% in girls with chronic, recurrent &#x201C;very brief&#x201D; headaches. In an earlier study of the EEG and migraine [<xref ref-type="bibr" rid="CIT0004">4</xref>], epileptiform EEGs were found in 18% of 100 consecutive children with recurrent headache, and the prevalence was the same in those with migraine as in the total group. In 30 patients with migraine in this series, a trial of the AED phenytoin as prophylactic therapy found that 77% were benefited, but the response to phenytoin was not correlated with an abnormal EEG, the factor that prompted this initial trial of an AED in childhood migraine; in 13 cases with abnormal and 17 with normal EEGs, response rates were 61% and 88%, respectively These findings support the view that a response to AED does not prove an epileptic or brain hyperexcitability mechanism for migraine headache. Less toxic and more specific AEDs than those currently available might prove of practical value in migraine prophylaxis.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welch</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention</article-title>
<source>Headache</source>
<year>2005</year>
<month>Apr</month>
<volume>45</volume>
<supplement>Suppl 1</supplement>
<fpage>S25</fpage>
<lpage>S32</lpage>
<pub-id pub-id-type="doi">10.1111/j.1526-4610.2005.4501008.x</pub-id>
<pub-id pub-id-type="pmid">15833087</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Nevo</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Neufeld</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The value of EEG in children with chronic headaches</article-title>
<source>Brain Dev</source>
<year>1994</year>
<month>Jul-Aug</month>
<volume>16</volume>
<issue>4</issue>
<fpage>304</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1016/0387-7604(94)90045-0</pub-id>
<pub-id pub-id-type="pmid">7818026</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gronseth</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature</article-title>
<source>Neurology</source>
<year>1995</year>
<month>Jul</month>
<volume>45</volume>
<issue>7</issue>
<fpage>1263</fpage>
<lpage>1267</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.45.7.1263</pub-id>
<pub-id pub-id-type="pmid">7617180</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millichap</surname>
<given-names>JG</given-names>
</name>
</person-group>
<source>Child&#x2019;s Brain</source>
<year>1978</year>
<volume>4</volume>
<fpage>95</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="pmid">639603</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>